FDA VRBPAC to Meet April 6 to Discuss Future COVID-19 Boosters
The U.S. Food and Drug Administration (FDA) announced it will convene a virtual meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Wednesday, April 6 to discuss considerations for future COVID-19 vaccine booster doses and the process for selecting specific strains of the SARS-CoV-2 virus for COVID-19 vaccines to address current and…
Read More »